featured
Efficacy and Safety of NOACs vs Warfarin Across the Spectrum of BMI and Body Weight in Patients With Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibrillation
Circulation 2024 Jan 24;[EPub Ahead of Print], SM Patel, E Braunwald, J Steffel, G Boriani, MG Palazzolo, EM Antman, EA Bohula, AP Carnicelli, SJ Connolly, J Eikelboom, B Gencer, CB Granger, DA Morrow, MR Patel, L Wallentin, CT Ruff, RP GiuglianoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.